New Enterprise Associates 16, L.P. 13D and 13G filings for Marker Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-12-23 4:30 pm Purchase |
2024-12-19 | 13D | Marker Therapeutics, Inc. MRKR |
New Enterprise Associates 16, L.P. | 1,625,678 15.200% |
554,250 (+51.73%) |
Filing |
| 2024-05-17 6:25 pm Purchase |
2024-05-15 | 13D | Marker Therapeutics, Inc. MRKR |
New Enterprise Associates 16, L.P. | 1,071,428 12.000% |
1,071,428 (New Position) |
Filing |